Chief Development Officer of Trillium Therapeutics Inc. (NASDAQ:TRIL), Petrova Penka, sells 5,312 shares worth $67,197
According to Trillium Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:18 PM, company Chief Development Officer, Petrova Penka disclosed selling 5,312 shares at a cost of $12.65. At the time of this transaction (Feb 08), this trade was worth $67,197 in total. As of Feb 08, Petrova Penka now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Trillium Therapeutics Inc. (NASDAQ:TRIL) Chief Development Officer, Petrova Penka, we have the following information:
- SEC Form 4 filing: Feb 09: Sold 508 shares at the rate of $14.17 per share. Total worth of this trade was $7,200. Total number of shares owned as of Feb 09 were 0
- SEC Form 4 filing: Jan 11: Sold 508 shares at the rate of $15.21 per share. Total worth of this trade was $7,725. Total number of shares owned as of Jan 11 were 0
- SEC Form 4 filing: Jan 08: Sold 2,604 shares at the rate of $15.50 per share. Total worth of this trade was $40,365. Total number of shares owned as of Jan 08 were 0
Posted by
George Daniels
on Wednesday February 10 2021, 10:36 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
